| 标题 |
IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Mauricio Burotto; Zanete Zvirbule; A. Mochalova; Y. Runglodvatana; Luis A. Herráez-Baranda; et al 出版日期:2023-06-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)